Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.
about
Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton InvolvementSomatostatin inhibits cell migration and reduces cell counts of human keratinocytes and delays epidermal wound healing in an ex vivo wound modelBiological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms.Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endotheliumSomatostatin analogs and radiopeptides in cancer therapy.Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance.Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2.Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells.Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1.sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.The biology and physiology of somatostatin receptors.Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureExpression of somatostatin and its receptor 1-5 in endometriotic tissues and cells
P2860
Q26770701-87BCBCA9-0B3B-4DA3-8B5B-48CFC6A37BB1Q28740304-55531656-67BF-4F21-81D5-9CACFB857BB4Q30333358-897B8FAD-1D41-4B15-B15E-01637FB266F4Q30486819-43390E8F-A503-42BB-B7C2-7413BE329FEAQ34972896-C74DF5C4-4EDB-430D-9C5C-ED14A714BEDEQ35020349-DDA79548-A647-4659-9CA7-1C4DE2B6AE63Q35216414-514516B6-3354-4D52-AA84-5E027B1C37D1Q35891113-BDD75602-B776-47B5-B845-6912D3F1EAA7Q36619058-033DE166-9FED-4D7D-9CDA-83AA0F80E0CCQ36739229-BA381C64-497F-4D3D-B78A-56375CB13D41Q36950543-84FF4CB9-AA52-493C-9A36-687F430584EEQ37244709-801A4786-998D-4371-B084-F2BFE0D91FF9Q37579225-A6D61900-954E-4FA0-BE18-49C0616B51E1Q38325005-7384DD00-3F19-4EB3-8263-2B38A2C01504Q38406569-81EF7B92-FDAF-472D-A0F5-6E5267292314Q38990078-AD34CF82-D937-40FE-8C15-ABCCE611F4B0Q40165727-A41078D7-D644-4A09-9E76-A4DF71F07612Q40281065-3C91BF54-A034-4B77-BF23-A18632E0F6CAQ41902731-E422A243-591C-4D1C-91C3-7D4809E789FDQ42438003-41FA8BD8-62D1-406D-94D1-4A14CA2974C4Q42452314-54F47553-122D-40D9-B988-95E1C1352E65Q44524136-AEB84C90-1A91-4BBE-8BB6-D0146C894EA4Q46245973-2AF0E937-904E-409E-98B1-5D5A38704950Q47992702-98BB4159-5C44-4149-9308-A4054F4B3AD1Q49352143-66DFD7EE-FF1E-43A9-89BA-13904A7F0AFFQ53670860-D7365D27-8604-4C8D-923E-896A1F6838E6Q57144951-DB28EAA6-53E5-4710-928D-38598EDBC465Q58552314-F695897E-509B-489A-A7F5-51C38EC3BDD6
P2860
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Characterization of the antipr ...... ostatin receptor subtype sst5.
@ast
Characterization of the antipr ...... ostatin receptor subtype sst5.
@en
type
label
Characterization of the antipr ...... ostatin receptor subtype sst5.
@ast
Characterization of the antipr ...... ostatin receptor subtype sst5.
@en
prefLabel
Characterization of the antipr ...... ostatin receptor subtype sst5.
@ast
Characterization of the antipr ...... ostatin receptor subtype sst5.
@en
P2093
P2860
P356
P1476
Characterization of the antipr ...... ostatin receptor subtype sst5.
@en
P2093
A M O'Carroll
A V Schally
C Bousquet
J P Estève
N Delesque
P Cordelier
P2860
P304
P356
10.1073/PNAS.94.17.9343
P407
P577
1997-08-01T00:00:00Z